Probiotics in the intensive care unit

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: To examine current knowledge regarding the utility of probiotics in a variety of medical conditions afflicting critically ill patients in the intensive care unit (ICU). RECENT FINDINGS: Recent experimental and clinical studies have furthered our understanding regarding the use of probiotic therapy across various clinical conditions. These disorders include antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, acute pancreatitis, ventilator-associated pneumonia, and sepsis among others. Although each of these conditions is germane to ICU patients, few studies have specifically studied this vulnerable population. The current data supporting the use of probiotics in the treatment of these different clinical conditions consist mostly of the results of small, single-center trials with varying quality of research design. Although recent studies have also generally demonstrated favorable results, one well designed study in severe pancreatitis found increased mortality with probiotic therapy. These results emphasize the need for improved data regarding mechanisms of action as well as rigorous attention to safety monitoring during the execution of probiotic clinical trials. SUMMARY: Data supporting the use of probiotics in different clinical conditions are variable in scope and quality. Large, well designed, randomized, multicenter trials are needed to better define the role and safety of probiotics in critically ill patients.

Original languageEnglish
Pages (from-to)144-148
Number of pages5
JournalCurrent Opinion in Critical Care
Volume15
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Probiotics
Intensive Care Units
Critical Illness
Pancreatitis
Diarrhea
Safety
Ventilator-Associated Pneumonia
Clostridium difficile
Vulnerable Populations
Multicenter Studies
Sepsis
Research Design
Therapeutics
Clinical Trials
Anti-Bacterial Agents
Mortality

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cite this

Probiotics in the intensive care unit. / Morrow, Lee E.

In: Current Opinion in Critical Care, Vol. 15, No. 2, 04.2009, p. 144-148.

Research output: Contribution to journalReview article

@article{f2af054f38ea4379a96351709547235e,
title = "Probiotics in the intensive care unit",
abstract = "PURPOSE OF REVIEW: To examine current knowledge regarding the utility of probiotics in a variety of medical conditions afflicting critically ill patients in the intensive care unit (ICU). RECENT FINDINGS: Recent experimental and clinical studies have furthered our understanding regarding the use of probiotic therapy across various clinical conditions. These disorders include antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, acute pancreatitis, ventilator-associated pneumonia, and sepsis among others. Although each of these conditions is germane to ICU patients, few studies have specifically studied this vulnerable population. The current data supporting the use of probiotics in the treatment of these different clinical conditions consist mostly of the results of small, single-center trials with varying quality of research design. Although recent studies have also generally demonstrated favorable results, one well designed study in severe pancreatitis found increased mortality with probiotic therapy. These results emphasize the need for improved data regarding mechanisms of action as well as rigorous attention to safety monitoring during the execution of probiotic clinical trials. SUMMARY: Data supporting the use of probiotics in different clinical conditions are variable in scope and quality. Large, well designed, randomized, multicenter trials are needed to better define the role and safety of probiotics in critically ill patients.",
author = "Morrow, {Lee E.}",
year = "2009",
month = "4",
doi = "10.1097/MCC.0b013e3283252d2d",
language = "English",
volume = "15",
pages = "144--148",
journal = "Current Opinion in Critical Care",
issn = "1070-5295",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Probiotics in the intensive care unit

AU - Morrow, Lee E.

PY - 2009/4

Y1 - 2009/4

N2 - PURPOSE OF REVIEW: To examine current knowledge regarding the utility of probiotics in a variety of medical conditions afflicting critically ill patients in the intensive care unit (ICU). RECENT FINDINGS: Recent experimental and clinical studies have furthered our understanding regarding the use of probiotic therapy across various clinical conditions. These disorders include antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, acute pancreatitis, ventilator-associated pneumonia, and sepsis among others. Although each of these conditions is germane to ICU patients, few studies have specifically studied this vulnerable population. The current data supporting the use of probiotics in the treatment of these different clinical conditions consist mostly of the results of small, single-center trials with varying quality of research design. Although recent studies have also generally demonstrated favorable results, one well designed study in severe pancreatitis found increased mortality with probiotic therapy. These results emphasize the need for improved data regarding mechanisms of action as well as rigorous attention to safety monitoring during the execution of probiotic clinical trials. SUMMARY: Data supporting the use of probiotics in different clinical conditions are variable in scope and quality. Large, well designed, randomized, multicenter trials are needed to better define the role and safety of probiotics in critically ill patients.

AB - PURPOSE OF REVIEW: To examine current knowledge regarding the utility of probiotics in a variety of medical conditions afflicting critically ill patients in the intensive care unit (ICU). RECENT FINDINGS: Recent experimental and clinical studies have furthered our understanding regarding the use of probiotic therapy across various clinical conditions. These disorders include antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, acute pancreatitis, ventilator-associated pneumonia, and sepsis among others. Although each of these conditions is germane to ICU patients, few studies have specifically studied this vulnerable population. The current data supporting the use of probiotics in the treatment of these different clinical conditions consist mostly of the results of small, single-center trials with varying quality of research design. Although recent studies have also generally demonstrated favorable results, one well designed study in severe pancreatitis found increased mortality with probiotic therapy. These results emphasize the need for improved data regarding mechanisms of action as well as rigorous attention to safety monitoring during the execution of probiotic clinical trials. SUMMARY: Data supporting the use of probiotics in different clinical conditions are variable in scope and quality. Large, well designed, randomized, multicenter trials are needed to better define the role and safety of probiotics in critically ill patients.

UR - http://www.scopus.com/inward/record.url?scp=67749130932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749130932&partnerID=8YFLogxK

U2 - 10.1097/MCC.0b013e3283252d2d

DO - 10.1097/MCC.0b013e3283252d2d

M3 - Review article

VL - 15

SP - 144

EP - 148

JO - Current Opinion in Critical Care

JF - Current Opinion in Critical Care

SN - 1070-5295

IS - 2

ER -